Heather D. Turner is VP & Secretary at Atara Biotherapeutics, Inc. (ATRA). They have made 3 open-market trades across 2 companies since 2012, most recently 2019-02-25.
CIK 0001403571
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRA | SELL | 2018-02-09 | 2018-02-12 | $37.87 | $852K | +12.1% | +7.0% | +12.9% |
| ATRA | SELL | 2017-02-09 | 2017-02-10 | $15.71 | $374K | -2.6% | +49.3% | +0.3% |
| OREX | SELL · 10b5-1 | 2014-12-02 | 2014-12-04 | $6.00 | $136K | N/A | N/A | N/A |
| OREX | SELL · 10b5-1 | 2014-11-24 | 2014-11-26 | $5.82 | $183K | N/A | N/A | N/A |
| OREX | SELL | 2014-09-22 | 2014-09-22 | $4.47 | $1.3M | N/A | N/A | N/A |
| OREX | SELL · 10b5-1 | 2012-07-17 | 2012-07-19 | $7.68 | $633K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.